Importantly, the functional importance of DSG2/Siglec‐9 interaction could be replicated in lung cancer and cervical cancer cell lines with high DSG2 expressions, suggesting DSG2 might be a potential target in cancer immunotherapy. The gene discussed is SIGLEC9; the disease is cancer.